Dr. Joan Mannick—mTOR's Role in Aging
Longevity by Design
00:00
Can Catalytic Inhibitors Really Work?
There's these peaks of death during winter cold and flu season. So we would treat people just once a day with these very low doses to up regulate this antiviral immunity that may also help with the vaccine response. It could be a combination or could just be let's just try and get viruses where we don't have a vaccine and help people with them. But I think we're getting closer and closer to understanding how do you use these drugs to really have clinical benefit? What's the end point? What can these really do? What can't they do? What population benefits?"
Transcript
Play full episode
